GlassScriptPhysician profile
Brent Pennington
NPI 1881670719
$7,077.00
in general payments reported to CMS, 2019-2025
31 companies · $1,625 in 2025
The $1,625 reported for 2025 was more than what 85% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,511 · 2020: $386 · 2021: $433 · 2022: $933 · 2023: $969 · 2024: $1,221 · 2025: $1,625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,749 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,748.53 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $953.98 | 2019-2025 | |
| Abbvie INC. | $842.95 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $613.98 | 2019-2025 | Dupixent, Libtayo |
| Organogenesis INC. | $498.85 | 2020-2025 | Puraply, Novachor, Puraply Wound Matrix |
| Janssen Biotech, INC. | $369.83 | 2019-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $361.73 | 2019-2025 | Ilumya |
| Leo Pharma INC. | $353.38 | 2019-2025 | Adbry |
| Incyte Corporation | $348.54 | 2022-2025 | Opzelura |
| Amgen INC. | $333.31 | 2020-2025 | Otezla, Otezla |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $308.03 | 2019-2025 | Jublia, Cabtreo, Arazlo |
| Ucb, INC. | $293.79 | 2019-2025 | Bimzelx |
| Genzyme Corporation | $240.51 | 2021-2025 | |
| Almirall LLC | $214.08 | 2019-2025 | Seysara |
| E.R. Squibb & Sons, L.L.C. | $181.14 | 2022-2024 | Sotyktu |
| Lilly USA, LLC | $156.45 | 2019-2023 | Taltz, Olumiant |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $112.82 | 2019-2020 | |
| Pfizer INC. | $96.72 | 2019-2024 | |
| Kerecis Limited | $93.19 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Convatec INC. | $90.21 | 2025 | |
| Dermavant Sciences, INC. | $88.24 | 2022-2024 | Vtama |
| Biofrontera INC. | $78.89 | 2019-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Genentech USA, INC. | $75.44 | 2019-2022 | |
| Progenacare Global, LLC | $70.35 | 2023 | |
| Celgene Corporation | $65.52 | 2019 | |
| Organon LLC | $51.06 | 2024-2025 | Vtama |
| Allergan, INC. | $45.78 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.69 | 2022-2025 | Spevigo |
| Galderma Laboratories, L.P. | $31.98 | 2025 | Nemluvio |
| Bioventus LLC | $30.11 | 2022 | |
| Verrica Pharmaceuticals INC. | $17.87 | 2024 | Ycanth |
| Journey Medical Corporation | $15.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Pennington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.